List of inhaled bronchodilators for COPD therapy currently prescribable through the Australian PBS scheme (see link below). Nothing analogous to nadalol is listed. Plenty of beta-2 receptor agonists but no beta-2 receptor antagonists such as nadalol. So natalol may well become a first in class therapy for COPD. Listen to the BRR interview with Dr Mitchell Glass to get a better idea of what the potential might be.
http://www.nps.org.au/publications/...sue/brief-item-pharmacological-copd-therapies
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.6¢ |
Change
-0.004(4.00%) |
Mkt cap ! $8.199M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.6¢ | $5.005K | 50.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 75868 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 278199 | 3 |
View Market Depth
| Last trade - 15.03pm 31/07/2025 (20 minute delay) ? |
| IVX (ASX) Chart |